{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:19:26Z","timestamp":1790864366607,"version":"4.1.0"},"reference-count":28,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T00:00:00Z","timestamp":1673913600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoma in adults. We evaluated the immunohistochemical (IHC) expression of p63 and p53 in DLBCL and their significance on overall survival (OS) and progression-free survival (PFS). We conducted a retrospective cohort study of 177 patients with DLBCL who presented to Mount Sinai Medical Center of Florida (Miami Beach, Florida) between 2010 and 2020. IHC staining for p63 and p53 protein expression was performed. A significant correlation was found between p63 positivity and p53 expression, p53\/p63 co-positivity, Ki-67 proliferation index, MYC expression, and MYC\/BCL2 double expression. Regardless of the germinal center B-cell like (GCB) subgrouping, there was a trend among p53+ patients to have MYC\/BCL2 double expression, positive MYC expression, and lower OS and PFS. A tendency of poor OS was seen in p53+ patients in the non-GCB, GCB, and double expressors subgroups and poor PFS in p53+ patients regardless of the subgrouping. In conclusion, our results suggest that p63 and p53 may represent potential additional prognostic biomarkers in DLBCL and may be included in the initial diagnostic work up of patients with DLBCL.<\/jats:p>","DOI":"10.3390\/curroncol30020102","type":"journal-article","created":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T03:04:44Z","timestamp":1674011084000},"page":"1314-1331","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Prognostic Significance of p53 and p63 in Diffuse Large B-Cell Lymphoma: A Single-Institution Experience"],"prefix":"10.3390","volume":"30","author":[{"given":"Juan","family":"Moreno","sequence":"first","affiliation":[{"name":"Arkadi M. Rywlin M.D. Department of Pathology and Laboratory Medicine, Mount Sinai Medical Center, Miami Beach, FL 33140, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisham","family":"Bahmad","sequence":"additional","affiliation":[{"name":"Arkadi M. Rywlin M.D. Department of Pathology and Laboratory Medicine, Mount Sinai Medical Center, Miami Beach, FL 33140, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8293-9772","authenticated-orcid":false,"given":"Abed","family":"Aljamal","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Mount Sinai Medical Center, Miami Beach, FL 33140, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"Delgado","sequence":"additional","affiliation":[{"name":"Arkadi M. Rywlin M.D. Department of Pathology and Laboratory Medicine, Mount Sinai Medical Center, Miami Beach, FL 33140, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3343-4035","authenticated-orcid":false,"given":"Ali","family":"Salami","sequence":"additional","affiliation":[{"name":"Department of Mathematics, Faculty of Sciences, Lebanese University, Nabatieh 1700, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Guillot","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine, Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amilcar","family":"Castellano-S\u00e1nchez","sequence":"additional","affiliation":[{"name":"Arkadi M. Rywlin M.D. Department of Pathology and Laboratory Medicine, Mount Sinai Medical Center, Miami Beach, FL 33140, USA"},{"name":"Department of Translational Medicine, Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Medina","sequence":"additional","affiliation":[{"name":"Arkadi M. Rywlin M.D. Department of Pathology and Laboratory Medicine, Mount Sinai Medical Center, Miami Beach, FL 33140, USA"},{"name":"Department of Translational Medicine, Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vathany","family":"Sriganeshan","sequence":"additional","affiliation":[{"name":"Arkadi M. Rywlin M.D. Department of Pathology and Laboratory Medicine, Mount Sinai Medical Center, Miami Beach, FL 33140, USA"},{"name":"Department of Translational Medicine, Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.critrevonc.2012.12.009","article-title":"Diffuse large B-cell lymphoma","volume":"87","author":"Martelli","year":"2013","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"6524","DOI":"10.1038\/sj.onc.1207843","article-title":"The epidemiology of non-Hodgkin\u2019s lymphoma","volume":"23","author":"Fisher","year":"2004","journal-title":"Oncogene"},{"key":"ref_3","unstructured":"Gandhi, S., Kallab, A.M., and Hernandez-Ilizaliturri, F.J. (2022, August 06). Diffuse Large B-Cell Lymphoma (DLBCL). Available online: https:\/\/emedicine.medscape.com\/article\/202969-overview#a5."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1200\/JCO.2016.70.0765","article-title":"Minimal Loss of Lifetime for Patients with Diffuse Large B-Cell Lymphoma in Remission and Event Free 24 Months After Treatment: A Danish Population-Based Study","volume":"35","author":"Jakobsen","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"ref_5","unstructured":"Swerdlow, S.H., Campo, E., Harris, N.L., Jaffe, E.S., Pileri, S.A., Stein, H., and Thiele, J. (2017). WHO Classification of Tumours, IARC Publications. [4th ed.]."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1200\/JCO.2005.05.1003","article-title":"Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma","volume":"24","author":"Habermann","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa011795","article-title":"CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma","volume":"346","author":"Coiffier","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1093\/annonc\/mdu109","article-title":"Prognostic factors for diffuse large B-cell lymphoma in the R(X)CHOP era","volume":"25","author":"Vaidya","year":"2014","journal-title":"Ann. Oncol."},{"key":"ref_9","first-page":"494","article-title":"p63 expression profiles in human normal and tumor tissues","volume":"8","author":"Urist","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/path.1231","article-title":"Differential expression of p63 isoforms in normal tissues and neoplastic cells","volume":"198","author":"Nylander","year":"2002","journal-title":"J. Pathol."},{"key":"ref_11","first-page":"337","article-title":"p53 family update: p73 and p63 develop their own identities","volume":"12","author":"Irwin","year":"2001","journal-title":"Cell Growth Differ."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1097-2765(00)80275-0","article-title":"p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities","volume":"2","author":"Yang","year":"1998","journal-title":"Mol. Cell"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/j.1349-7006.2006.00284.x","article-title":"Clinico-pathological characteristics of p63 expression in B-cell lymphoma","volume":"97","author":"Fukushima","year":"2006","journal-title":"Cancer Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13000-019-0880-7","article-title":"Expression of P63 and its correlation with prognosis in diffuse large B-cell lymphoma: A single center experience","volume":"14","author":"Hu","year":"2019","journal-title":"Diagn. Pathol."},{"key":"ref_15","first-page":"345","article-title":"p63 expression confers significantly better survival outcomes in high-risk diffuse large B-cell lymphoma and demonstrates p53-like and p53-independent tumor suppressor function","volume":"8","author":"Zhang","year":"2016","journal-title":"Aging (Albany N.Y.)"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/jcp.2008.059519","article-title":"p63 protein expression in high risk diffuse large B-cell lymphoma","volume":"62","author":"Siqueira","year":"2009","journal-title":"J. Clin. Pathol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1309\/AJCPPHMZ6VHF0WQV","article-title":"p53 expression is a strong marker of inferior survival in de novo diffuse large B-cell lymphoma and may have enhanced negative effect with MYC coexpression: A single institutional clinicopathologic study","volume":"141","author":"Xie","year":"2014","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/s41379-021-00745-6","article-title":"A new tool for technical standardization of the Ki67 immunohistochemical assay","volume":"34","author":"Aung","year":"2021","journal-title":"Mod. Pathol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: Open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1093\/jnci\/92.15.1240","article-title":"Cancer surveillance series: Non-Hodgkin\u2019s lymphoma incidence by histologic subtype in the United States from 1978 through 1995","volume":"92","author":"Groves","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/sj.thj.6200154","article-title":"Increasing incidence and descriptive epidemiology of extranodal non-Hodgkin lymphoma in parts of England and Wales","volume":"3","author":"Gurney","year":"2002","journal-title":"Hematol. J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.1002\/cncr.31646","article-title":"Double hit and double expressors in lymphoma: Definition and treatment","volume":"124","author":"Riedell","year":"2018","journal-title":"Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"701986","DOI":"10.3389\/fcell.2021.701986","article-title":"p63 and p53: Collaborative Partners or Dueling Rivals?","volume":"9","author":"Woodstock","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.3109\/10428194.2012.684348","article-title":"Role of p53 family members p73 and p63 in human hematological malignancies","volume":"53","author":"Alexandrova","year":"2012","journal-title":"Leuk. Lymphoma"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/01.pai.0000142160.52670.ce","article-title":"Expression of p63 in diffuse large B-cell lymphoma","volume":"13","author":"Hedvat","year":"2005","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/his.12855","article-title":"Immunocytochemical p63 expression discriminates between primary cutaneous follicle centre cell and diffuse large B cell lymphoma-leg type, and is of the TAp63 isoform","volume":"69","author":"Robson","year":"2016","journal-title":"Histopathology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"752","DOI":"10.3346\/jkms.2005.20.5.752","article-title":"Expression of p63 in reactive hyperplasias and malignant lymphomas","volume":"20","author":"Park","year":"2005","journal-title":"J. Korean Med. Sci."}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/30\/2\/102\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:08:25Z","timestamp":1760119705000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/30\/2\/102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,17]]},"references-count":28,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["curroncol30020102"],"URL":"https:\/\/doi.org\/10.3390\/curroncol30020102","relation":{},"ISSN":["1718-7729"],"issn-type":[{"value":"1718-7729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,17]]}}}